Tai Sandi See - Chief Development Officer at Lexeo Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Development Officer
Issuer Symbol
LXEO on Nasdaq
All Insider Reports
All Insider Reports

Tai Sandi See - trading volume in the past year for Lexeo Therapeutics, Inc.

Holdings reported by Tai Sandi See for Lexeo Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 65,476 $606,962 $9.27 18 Nov 2025 Direct
Stock Option (right to buy) 77,500 07 Jan 2025 Direct Common Stock

Transactions reported by Tai Sandi See for Lexeo Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.